KalVista Pharmaceuticals
KALV
KALV
20 hedge funds and large institutions have $59.2M invested in KalVista Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
4.31% more ownership
Funds ownership: 73.83% → 78.14% (+4.3%)
0% more funds holding
Funds holding: 20 → 20 (0)
Holders
20
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
1 | +$1.11M | |
2 | +$766K | |
3 | +$86K | |
4 |
BFM
Boothbay Fund Management
New York
|
+$41.5K |
5 |
BlackRock
New York
|
+$27K |